A panel of human cell-based artificial APC enables the expansion of long-lived antigen-specific CD4+ T cells restricted by prevalent HLA-DR alleles.
Int. Immunol., Nov;22(11):863-73 (2010)
Expansion of allospecific regulatory T cells after anergized, mismatched bone marrow transplantation.
Sci Transl Med., Oct;1(1):1ra3 (2009)
Dissociation of its opposing immunologic effects is critical for the optimization of antitumor CD8+ T-cell responses induced by interleukin 21.
Clin. Cancer Res., Oct;14(19):6125-36 (2008)
Induction of alloanergy in human donor T cells without loss of pathogen or tumor immunity.
Transplantation., Sep;86(6):854-64 (2008)
CpG oligodeoxynucleotides alter lymphocyte and dendritic cell trafficking in humans.
Clin. Cancer Res., Sep;14(17):5626-34 (2008)
Outcome of alloanergized haploidentical bone marrow transplantation after ex vivo costimulatory blockade: results of 2 phase 1 studies.
Blood., Sep;112(6):2232-41 (2008)
Identification of an evolutionarily conserved transcriptional signature of CD8 memory differentiation that is shared by T and B cells.
J. Immunol., Aug;181(3):1859-68 (2008)
Long-term survival after autologous bone marrow transplantation for follicular lymphoma in first remission.
Biol. Blood Marrow Transplant., Sep;13(9):1057-65 (2007)
Measuring T cell immunity to influenza vaccination in children after haemopoietic stem cell transplantation.
Br. J. Haematol., Nov;127(3):322-5 (2004)
Common gamma chain-signaling cytokines promote proliferation of T-cell acute lymphoblastic leukemia.
Haematologica., Dec;89(12):1459-67 (2004)
Presence of anti-kinectin and anti-PMS1 antibodies in Japanese aplastic anaemia patients.
Br. J. Haematol., Jan;128(2):221-3 (2005)
Failure to define window of time for autologous tumor vaccination in patients with newly diagnosed or relapsed acute lymphoblastic leukemia.
Exp. Hematol., Mar;33(3):286-94 (2005)
Increasing incidence of late second malignancies after conditioning with cyclophosphamide and total-body irradiation and autologous bone marrow transplantation for non-Hodgkin's lymphoma.
J. Clin. Oncol., Apr;23(10):2208-14 (2005)
Antigen-specific T-cell memory is preserved in children treated for acute lymphoblastic leukemia.
Blood., Sep;106(5):1749-54 (2005)
Unexpected association between induction of immunity to the universal tumor antigen CYP1B1 and response to next therapy.
Clin. Cancer Res., Jun;11(12):4430-6 (2005)
Phase I/II combined chemoimmunotherapy with carcinoembryonic antigen-derived HLA-A2-restricted CAP-1 peptide and irinotecan, 5-fluorouracil, and leucovorin in patients with primary metastatic colorectal cancer.
Clin. Cancer Res., Aug;11(16):5993-6001 (2005)
Proangiogenic stimulation of bone marrow endothelium engages mTOR and is inhibited by simultaneous blockade of mTOR and NF-kappaB.
Blood., Jan;107(1):285-92 (2006)
Engagement of CD83 ligand induces prolonged expansion of CD8+ T cells and preferential enrichment for antigen specificity.
Blood., Feb;107(4):1528-36 (2006)
Gene expression profiling identifies BAX-delta as a novel tumor antigen in acute lymphoblastic leukemia.
Cancer Res., Nov;65(21):10050-8 (2005)
Leukemia-stimulated bone marrow endothelium promotes leukemia cell survival.
Exp. Hematol., May;34(5):610-21 (2006)